Key facts
- Notable investors include Xfund.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Can9 Bioengineering
- ·The full record, as it builds
Funding rounds
No funding rounds for Can9 Bioengineering are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Can9 Bioengineering
Provider of biotechnology research services intended to focus on genetics research in canines. The company is currently operating in stealth mode.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2019
- Employees
- 2
- Website
- can9bio.com/
- Ownership
- Privately Held (backing)
Can9 Bioengineering doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Can9 Bioengineering shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Can9 Bioengineering in its N-PORT filings yet. We sweep new filings monthly.